Everolimus Plus Itacitinib in Relapsed/Refractory Classical Hodgkin Lymphoma: Results of a Phase I/II Investigator Initiated Trial (EVITA Study)

Jakub Svoboda; Stefan K. Barta; Daniel J. Landsburg; Sunita Dwivedy Nasta; Wei Hwang; Grace Delp; Brittany Amundsen; Hatcher J. Ballard; James N. Gerson; Elise A. Chong; Mitchell E. Hughes; Steven A. Emanuel; Marco Ruella; Stephen J. Schuster

doi:10.1182/blood-2020-140507

Everolimus Plus Itacitinib in Relapsed/Refractory Classical Hodgkin Lymphoma: Results of a Phase I/II Investigator Initiated Trial (EVITA Study)

Jakub Svoboda
, Stefan K. Barta
, Daniel J. Landsburg
, Sunita Dwivedy Nasta
, Wei Hwang
, Grace Delp
, Brittany Amundsen
, Hatcher J. Ballard
, James N. Gerson
, Elise A. Chong
, Mitchell E. Hughes
, Steven A. Emanuel
, Marco Ruella
, Stephen J. Schuster

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Pages (from-to)	20-21
Number of pages	2
Journal	Blood
Volume	136(Supplement 1)
DOIs	https://doi.org/10.1182/blood-2020-140507
State	Published - 5 Nov 2020

Access to Document

10.1182/blood-2020-140507

Cite this

Svoboda, J., Barta, S. K., Landsburg, D. J., Nasta, S. D., Hwang, W., Delp, G., Amundsen, B., Ballard, H. J., Gerson, J. N., Chong, E. A., Hughes, M. E., Emanuel, S. A., Ruella, M., & Schuster, S. J. (2020). Everolimus Plus Itacitinib in Relapsed/Refractory Classical Hodgkin Lymphoma: Results of a Phase I/II Investigator Initiated Trial (EVITA Study). Blood, 136(Supplement 1), 20-21. https://doi.org/10.1182/blood-2020-140507

@article{a9a4cf20b6414e90821ea945c7d22c5f,

title = "Everolimus Plus Itacitinib in Relapsed/Refractory Classical Hodgkin Lymphoma: Results of a Phase I/II Investigator Initiated Trial (EVITA Study)",

author = "Jakub Svoboda and Barta, \{Stefan K.\} and Landsburg, \{Daniel J.\} and Nasta, \{Sunita Dwivedy\} and Wei Hwang and Grace Delp and Brittany Amundsen and Ballard, \{Hatcher J.\} and Gerson, \{James N.\} and Chong, \{Elise A.\} and Hughes, \{Mitchell E.\} and Emanuel, \{Steven A.\} and Marco Ruella and Schuster, \{Stephen J.\}",

year = "2020",

month = nov,

day = "5",

doi = "10.1182/blood-2020-140507",

language = "English",

volume = "136(Supplement 1)",

pages = "20--21",

journal = "Blood",

issn = "0006-4971",

publisher = "Elsevier B.V.",

}

Svoboda, J, Barta, SK, Landsburg, DJ, Nasta, SD, Hwang, W, Delp, G, Amundsen, B, Ballard, HJ, Gerson, JN, Chong, EA, Hughes, ME, Emanuel, SA, Ruella, M & Schuster, SJ 2020, 'Everolimus Plus Itacitinib in Relapsed/Refractory Classical Hodgkin Lymphoma: Results of a Phase I/II Investigator Initiated Trial (EVITA Study)', Blood, vol. 136(Supplement 1), pp. 20-21. https://doi.org/10.1182/blood-2020-140507

TY - JOUR

T1 - Everolimus Plus Itacitinib in Relapsed/Refractory Classical Hodgkin Lymphoma

T2 - Results of a Phase I/II Investigator Initiated Trial (EVITA Study)

AU - Svoboda, Jakub

AU - Barta, Stefan K.

AU - Landsburg, Daniel J.

AU - Nasta, Sunita Dwivedy

AU - Hwang, Wei

AU - Delp, Grace

AU - Amundsen, Brittany

AU - Ballard, Hatcher J.

AU - Gerson, James N.

AU - Chong, Elise A.

AU - Hughes, Mitchell E.

AU - Emanuel, Steven A.

AU - Ruella, Marco

AU - Schuster, Stephen J.

PY - 2020/11/5

Y1 - 2020/11/5

U2 - 10.1182/blood-2020-140507

DO - 10.1182/blood-2020-140507

M3 - Meeting Abstract

SN - 0006-4971

VL - 136(Supplement 1)

SP - 20

EP - 21

JO - Blood

JF - Blood

ER -